Literature DB >> 9472631

Effects of p53 mutants derived from lung carcinomas on the p53-responsive element (p53RE) of the MDM2 gene.

V G Gorgoulis1, P V Zacharatos, E Manolis, J A Ikonomopoulos, A Damalas, C Lamprinopoulos, G Z Rassidakis, V Zoumpourlis, A Kotsinas, A N Rassidakis, T D Halazonetis, C Kittas.   

Abstract

The present study represents a continuation of previous works in which we observed that lung carcinomas co-expressing MDM2 protein and p53 mutants (mt p53) exhibited more aggressive behaviour. In the above studies, we suggested a 'gain of function' mechanism of mt p53 proteins based on the fact that the MDM2 gene possesses a p53-responsive element (MDM2-p53RE). In this study, to prove our hypothesis, we selected 12 cases from a series of 51 bronchogenic carcinomas. In these 12 cases, we examined the ability of the expressed mt p53 to bind the MDM2-p53RE and correlated the findings with MDM2 expression. Furthermore, we constructed four of these p53 mutants and studied their transactivation properties by co-transfecting them with a reporter plasmid carrying MDM2-p53RE in the p53 null non-small-cell lung carcinoma cell line (NSCLC) H1299. We observed mutant p53 protein DNA-binding activity, which depended on the nature and the position of the amino acid substitution. The fact that the cases with DNA-binding activity were accompanied with MDM2 protein isoforms' overexpression is indicative of a 'gain of function' phenotype. This hypothesis was enforced by the findings of the transfection experiments, which revealed that certain p53 mutants enhanced the expression of the luciferase reporter gene either directly or indirectly via a dominant positive effect on the wild-type p53. In conclusion, this work is one first attempt to examine if the deregulation of the p53/MDM2 autoregulatory feedback loop is due to novel properties of certain p53 mutants in the specific environment of a subset of bronchogenic carcinomas.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9472631      PMCID: PMC2151306          DOI: 10.1038/bjc.1998.60

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  68 in total

Review 1.  Histologic grading of nodular sclerosing Hodgkin's disease: is it an independent prognostic factor?

Authors:  B M Osborne; C Bueso-Ramos
Journal:  Cancer Treat Res       Date:  1996

2.  Transactivational and DNA binding abilities of endogenous p53 in p53 mutant cell lines.

Authors:  D J Park; H Nakamura; A M Chumakov; J W Said; C W Miller; D L Chen; H P Koeffler
Journal:  Oncogene       Date:  1994-07       Impact factor: 9.867

3.  Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations.

Authors:  Y Cho; S Gorina; P D Jeffrey; N P Pavletich
Journal:  Science       Date:  1994-07-15       Impact factor: 47.728

4.  Interaction between the retinoblastoma protein and the oncoprotein MDM2.

Authors:  Z X Xiao; J Chen; A J Levine; N Modjtahedi; J Xing; W R Sellers; D M Livingston
Journal:  Nature       Date:  1995-06-22       Impact factor: 49.962

5.  Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein.

Authors:  K Martin; D Trouche; C Hagemeier; T S Sørensen; N B La Thangue; T Kouzarides
Journal:  Nature       Date:  1995-06-22       Impact factor: 49.962

Review 6.  Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.

Authors:  M S Greenblatt; W P Bennett; M Hollstein; C C Harris
Journal:  Cancer Res       Date:  1994-09-15       Impact factor: 12.701

7.  Two critical hydrophobic amino acids in the N-terminal domain of the p53 protein are required for the gain of function phenotypes of human p53 mutants.

Authors:  J Lin; A K Teresky; A J Levine
Journal:  Oncogene       Date:  1995-06-15       Impact factor: 9.867

8.  Isolation and characterization of a human p53 cDNA clone: expression of the human p53 gene.

Authors:  G Matlashewski; P Lamb; D Pim; J Peacock; L Crawford; S Benchimol
Journal:  EMBO J       Date:  1984-12-20       Impact factor: 11.598

9.  Human p53 cellular tumor antigen: cDNA sequence and expression in COS cells.

Authors:  R Zakut-Houri; B Bienz-Tadmor; D Givol; M Oren
Journal:  EMBO J       Date:  1985-05       Impact factor: 11.598

10.  Analysis of the most representative tumour-derived p53 mutants reveals that changes in protein conformation are not correlated with loss of transactivation or inhibition of cell proliferation.

Authors:  K Ory; Y Legros; C Auguin; T Soussi
Journal:  EMBO J       Date:  1994-08-01       Impact factor: 11.598

View more
  6 in total

1.  p53 activates ICAM-1 (CD54) expression in an NF-kappaB-independent manner.

Authors:  Vassilis G Gorgoulis; Panayotis Zacharatos; Athanassios Kotsinas; Dimitris Kletsas; George Mariatos; Vassilis Zoumpourlis; Kevin M Ryan; Christos Kittas; Athanasios G Papavassiliou
Journal:  EMBO J       Date:  2003-04-01       Impact factor: 11.598

2.  Alterations of the p16-pRb pathway and the chromosome locus 9p21-22 in non-small-cell lung carcinomas: relationship with p53 and MDM2 protein expression.

Authors:  V G Gorgoulis; P Zacharatos; A Kotsinas; T Liloglou; A Kyroudi; M Veslemes; A Rassidakis; T D Halazonetis; J K Field; C Kittas
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

3.  Cdc6 expression represses E-cadherin transcription and activates adjacent replication origins.

Authors:  Maria Sideridou; Roubini Zakopoulou; Konstantinos Evangelou; Michalis Liontos; Athanassios Kotsinas; Emmanouil Rampakakis; Sarantis Gagos; Kaoru Kahata; Kristina Grabusic; Kalliopi Gkouskou; Ioannis P Trougakos; Evangelos Kolettas; Alexandros G Georgakilas; Sinisa Volarevic; Aristides G Eliopoulos; Maria Zannis-Hadjopoulos; Aristidis Moustakas; Vassilis G Gorgoulis
Journal:  J Cell Biol       Date:  2011-12-26       Impact factor: 10.539

4.  Bcl-2/Bax protein ratio predicts 5-fluorouracil sensitivity independently of p53 status.

Authors:  J F Mirjolet; M Barberi-Heyob; C Didelot; J P Peyrat; J Abecassis; R Millon; J L Merlin
Journal:  Br J Cancer       Date:  2000-11       Impact factor: 7.640

5.  The human oncoprotein MDM2 induces replication stress eliciting early intra-S-phase checkpoint response and inhibition of DNA replication origin firing.

Authors:  Rebecca A Frum; Shilpa Singh; Catherine Vaughan; Nitai D Mukhopadhyay; Steven R Grossman; Brad Windle; Sumitra Deb; Swati Palit Deb
Journal:  Nucleic Acids Res       Date:  2013-10-24       Impact factor: 16.971

Review 6.  Integrating the DNA damage and protein stress responses during cancer development and treatment.

Authors:  Vassilis G Gorgoulis; Dafni-Eleftheria Pefani; Ioannis S Pateras; Ioannis P Trougakos
Journal:  J Pathol       Date:  2018-07-19       Impact factor: 7.996

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.